Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 7.505 USD -0.6% Market Closed
Market Cap: 102m USD
Have any thoughts about
Champions Oncology Inc?
Write Note

Intrinsic Value

The intrinsic value of one CSBR stock under the Base Case scenario is 7.1 USD. Compared to the current market price of 7.505 USD, Champions Oncology Inc is Overvalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CSBR Intrinsic Value
7.1 USD
Overvaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Champions Oncology Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CSBR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CSBR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CSBR?
Bearish
Neutral
Bullish

Fundamental Analysis

7.505 USD
-0.6%
-0.6%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Champions Oncology Inc
US
Life Sciences Tools & Services
Market Cap
102.8m USD
IPO
Nov 30, 1988
Employees
194
United States of America
Market Cap
102.8m USD
Industry
Life Sciences Tools & Services
IPO
Nov 30, 1988
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Champions Oncology Inc

Provide an overview of the primary business activities
of Champions Oncology Inc.

What unique competitive advantages
does Champions Oncology Inc hold over its rivals?

What risks and challenges
does Champions Oncology Inc face in the near future?

Has there been any significant insider trading activity
in Champions Oncology Inc recently?

Summarize the latest earnings call
of Champions Oncology Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Champions Oncology Inc.

Provide P/S
for Champions Oncology Inc.

Provide P/E
for Champions Oncology Inc.

Provide P/OCF
for Champions Oncology Inc.

Provide P/FCFE
for Champions Oncology Inc.

Provide P/B
for Champions Oncology Inc.

Provide EV/S
for Champions Oncology Inc.

Provide EV/GP
for Champions Oncology Inc.

Provide EV/EBITDA
for Champions Oncology Inc.

Provide EV/EBIT
for Champions Oncology Inc.

Provide EV/OCF
for Champions Oncology Inc.

Provide EV/FCFF
for Champions Oncology Inc.

Provide EV/IC
for Champions Oncology Inc.

Show me price targets
for Champions Oncology Inc made by professional analysts.

What are the Revenue projections
for Champions Oncology Inc?

How accurate were the past Revenue estimates
for Champions Oncology Inc?

What are the Net Income projections
for Champions Oncology Inc?

How accurate were the past Net Income estimates
for Champions Oncology Inc?

What are the EPS projections
for Champions Oncology Inc?

How accurate were the past EPS estimates
for Champions Oncology Inc?

What are the EBIT projections
for Champions Oncology Inc?

How accurate were the past EBIT estimates
for Champions Oncology Inc?

Compare the revenue forecasts
for Champions Oncology Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Champions Oncology Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Champions Oncology Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Champions Oncology Inc compared to its peers.

Compare the P/E ratios
of Champions Oncology Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Champions Oncology Inc with its peers.

Analyze the financial leverage
of Champions Oncology Inc compared to its main competitors.

Show all profitability ratios
for Champions Oncology Inc.

Provide ROE
for Champions Oncology Inc.

Provide ROA
for Champions Oncology Inc.

Provide ROIC
for Champions Oncology Inc.

Provide ROCE
for Champions Oncology Inc.

Provide Gross Margin
for Champions Oncology Inc.

Provide Operating Margin
for Champions Oncology Inc.

Provide Net Margin
for Champions Oncology Inc.

Provide FCF Margin
for Champions Oncology Inc.

Show all solvency ratios
for Champions Oncology Inc.

Provide D/E Ratio
for Champions Oncology Inc.

Provide D/A Ratio
for Champions Oncology Inc.

Provide Interest Coverage Ratio
for Champions Oncology Inc.

Provide Altman Z-Score Ratio
for Champions Oncology Inc.

Provide Quick Ratio
for Champions Oncology Inc.

Provide Current Ratio
for Champions Oncology Inc.

Provide Cash Ratio
for Champions Oncology Inc.

What is the historical Revenue growth
over the last 5 years for Champions Oncology Inc?

What is the historical Net Income growth
over the last 5 years for Champions Oncology Inc?

What is the current Free Cash Flow
of Champions Oncology Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Champions Oncology Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Champions Oncology Inc

Current Assets 14.1m
Cash & Short-Term Investments 2.8m
Receivables 10.5m
Other Current Assets 860k
Non-Current Assets 11.2m
PP&E 10.6m
Intangibles 335k
Other Non-Current Assets 185k
Current Liabilities 18.9m
Accounts Payable 4.9m
Accrued Liabilities 3.6m
Other Current Liabilities 10.4m
Non-Current Liabilities 5.7m
Long-Term Debt 143k
Other Non-Current Liabilities 5.6m
Efficiency

Earnings Waterfall
Champions Oncology Inc

Revenue
53.6m USD
Cost of Revenue
-29.6m USD
Gross Profit
24m USD
Operating Expenses
-24.8m USD
Operating Income
-787k USD
Other Expenses
189k USD
Net Income
-598k USD

Free Cash Flow Analysis
Champions Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CSBR Profitability Score
Profitability Due Diligence

Champions Oncology Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
28/100
Profitability
Score

Champions Oncology Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

CSBR Solvency Score
Solvency Due Diligence

Champions Oncology Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

Champions Oncology Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CSBR Price Targets Summary
Champions Oncology Inc

Wall Street analysts forecast CSBR stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSBR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
19% Downside
Average
Price Target
6.12 USD
18% Downside
Highest
Price Target
6.3 USD
16% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CSBR?

Click here to dive deeper.

Dividends

Champions Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CSBR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CSBR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one CSBR stock?

The intrinsic value of one CSBR stock under the Base Case scenario is 7.1 USD.

Is CSBR stock undervalued or overvalued?

Compared to the current market price of 7.505 USD, Champions Oncology Inc is Overvalued by 5%.

Back to Top